<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220703055350N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-04</date_registration>
      <primary_sponsor>University of social welfare and rehabilitation sciences</primary_sponsor>
      <public_title>The effect of lateral balance training on falls in stroke</public_title>
      <acronym></acronym>
      <scientific_title>The effect of frontal plane-focused balance training on balance performance and falls in chronic stroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-17</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64596</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: The 4-volume random block allocation method will be used. All possible 4 permutations will be listed in two groups (permutations 1 to 6 are as follows) A is the intervention group and B is the control group. 1-AABB 2-ABAB 3-BAAB 4-BABA 5-BBAA 6-ABBA Then, from a random number table with a random starting point, 6 numbers between 1 and 6 will be randomly selected (either using software or randomaize.com). For example, if the 6 random numbers obtained are 3 5 4 3 4 6 , It will mean that the first four people similar to block 3, the second four people similar to block 5 and ... will be allocated, Blinding description: This study will be performed in a double-blind manner and the blinding includes the participants, the person who analyzes the data and the experimenters who perform the pre- and post-treatment and 6-month follow-up evaluation are blind to the group allocation. Furthermore,  physiotherapists who perform training are blind to pre-test, post-test and follow-up results.</study_design>
      <phase>N/A</phase>
      <hc_freetext>stroke.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Frontal plane-focused balance training, including static and dynamic exercises focused  on maintaining lateral balance. In the first 8 sessions single-task exercises will be accomplished. In the second 8 sessions motor dual task exercises will be done and in the third 8 sessions cognitive dual task exercises will be done. Intervention 2: Control group: Traditional balance training, including static and dynamic balance exercises focused on maintaining general and specially anterior- posterior balance. The same as intervention group, three 8-session therapeutic periods will be accomplished for the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After hiding of personal information, demographic data will be shareable

When:
Data will be accessible 6 months after publishing.

To whom:
It will be available to all scholars and researchers working in an academia or a research center.

Conditions:
For academic researches, confirming the ethics code is needed to access data .

Where to obtain:
To receive data, send an e-mail to Dr. Iraj Abdollahi via irajabdollahi@hotmail.com or  to Mitra Parsa via mitra.parsaa@gmail.com containing reasons for data access.

How to obtain:
It is imperative to explain the reasons for data access and features of research plan comprehensively.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Iraj Abdollahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>kodakyar Ave., daneshjo Blvd.,Evin</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985713871</zip>
        <telephone>+98 21 2218 0083</telephone>
        <email>irajabdollahi@hotmail.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mitra Parsa</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.198, 2nd Khaghani, Khaghani Blv., Rezashahr</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177753635</zip>
        <telephone>+98 51 3876 5444</telephone>
        <email>mitra0parsaa@gmail.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>First ischemic or hemorrhagic stroke attack
At least 6 months post stroke
Only half of body was involved
Be able to stand and walk for 1 minute and stand semi-tandem independently
Have stable condition and not to suffer from any other diseases that affect balance
Get 24 score or more in Mini-Mental State Examination (MMSE)
Get standard deviation less than ±1 in Line Bisection test (not to suffer from hemineglect)
have the score 2 or less in Modified Ashworth Scale in Gastrosoleos muscle</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Had a surgery on upper or lower extremity during last year
Have contracture or deformity in lower limb
Suffer from visual or auditory disorder
Begin to take vitamin D at the same training time</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Vascular syndromes of brain in cerebrovascular diseases</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Frontal plane-focused balance training, including static and dynamic exercises focused  on maintaining lateral balance. In the first 8 sessions single-task exercises will be accomplished. In the second 8 sessions motor dual task exercises will be done and in the third 8 sessions cognitive dual task exercises will be done.</i_keyword>
      <i_keyword>Control group: Traditional balance training, including static and dynamic balance exercises focused on maintaining general and specially anterior- posterior balance. The same as intervention group, three 8-session therapeutic periods will be accomplished for the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Center of pressure parameters (postural control or balance). Timepoint: before training (pretest), after training (post test) and after 6 months follow-up. Method of measurement: force platform (Kistler).</prim_outcome>
      <prim_outcome>Fall history (rate of falling [Rate ratio] and risk of falling [Odds ratio]). Timepoint: from CVA incidence to beginning of training. Method of measurement: self-reporting.</prim_outcome>
      <prim_outcome>Berg balance scale score. Timepoint: pre-test, post-test and after 6 months follow-up. Method of measurement: Berg balance scale.</prim_outcome>
      <prim_outcome>Mini- Balance Evaluation Systems Test (Mini-BEST) score. Timepoint: pre-test, post-test and after 6 months follow-up. Method of measurement: Mini-Best.</prim_outcome>
      <prim_outcome>Activities-specific Balance Confidence (ABC) test score. Timepoint: pre-test, post-test and after 6 months follow-up. Method of measurement: ABC test.</prim_outcome>
      <prim_outcome>Falls risk for older people in the community (FROP-Com) screening tool score. Timepoint: pre-test, post-test and after 6 months follow-up. Method of measurement: FROP-Com screening tool test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Motor task performance score. Timepoint: pre-test, post-test and after 6 months follow-up. Method of measurement: reversed average of acceleration absolute value (three directions) measured by an accelerometer attached to the tray.</sec_outcome>
      <sec_outcome>Cognitive task performance score. Timepoint: pre-test, post-test and after 6 months follow-up. Method of measurement: rate of correct words to total words in Stroop test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of social welfare and rehabilitation sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-11-25</approval_date>
        <contact_name>Ethics committee of university of social welfare and rehabilitation</contact_name>
        <contact_address>kodakyar Ave., daneshjo Blvd.,Evin Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
